Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Dyspnea
- Hypercapnia
- Respiratory Insufficiency
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Single (Participant)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The objective of this study is to evaluate the ability of HVNI next generation nasal cannula designs to effect ventilation and related physiological responses relative to the current cannula design, with which there are published clinical outcomes data. It is hypothesized that next generation nasal ...
The objective of this study is to evaluate the ability of HVNI next generation nasal cannula designs to effect ventilation and related physiological responses relative to the current cannula design, with which there are published clinical outcomes data. It is hypothesized that next generation nasal cannula designs (Prosoft and Unicorn) will be comparable at relieving patient dyspnea while on HVNI, when compared to the conventional (Legacy) cannula.
Tracking Information
- NCT #
- NCT04512781
- Collaborators
- VA Pittsburgh Healthcare System
- Investigators
- Principal Investigator: Charles W Atwood, MD, FCCP VA Pittsburgh Healthcare System Principal Investigator: Jigme M Sethi, MD, FCCP Erlanger Baroness Hospital
Get Well Soon